Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk. - Wikidata - wikimedia - TriplyDB

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

http://www.wikidata.org/entity/Q34177267

about

The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.Maternal and offspring xenobiotic metabolism haplotypes and the risk of childhood acute lymphoblastic leukemia mEH Tyr113His polymorphism and the risk of ovarian cancer development.Genetic enhancement of microsomal epoxide hydrolase improves metabolic detoxification but impairs cerebral blood flow regulation.Try113His and His139Arg polymorphisms in the microsomal epoxide hydrolase gene are not associated with risk of breast cancer.CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.Genetic variants associated with Fabry disease progression despite enzyme replacement therapy.Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma.Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia.

P2860

Q28294622-53CC1D13-EFF5-4F90-BF39-6DC79743440C Q28608628-C85E3662-71F2-4703-B4C5-54DC54DC6410 Q34364904-6FA963B5-8CEE-4D8A-9B7C-918EF862CC9A Q34602962-E6298BDF-41C4-4DE7-AA33-CCD2D567A4BB Q35440426-204A3532-EF4F-49A8-BF9D-2BFD1F3D625A Q36756043-567EAC69-0A64-445C-BF1F-84E5AA28A897 Q36926478-DB4DE24F-42D1-47AF-8FD5-EDCA183D9147 Q37408068-8EB01D01-E92F-42D4-B3BC-2B1D6F766CE8 Q38397833-BD48AF9E-8D79-4722-A745-77C7B2926264 Q38627269-911AB84F-5C0A-4336-A2AE-180884CCBBEE Q46522972-ABFDBD0E-ACD0-46A0-A044-09CF586BB15E Q47094778-3B987126-7CE5-403A-8975-FFAC4561986B Q53277915-4FD6ED9D-8DBD-45CE-BEBD-790E28E69763 Q53280617-C483280A-6BDB-4677-AE59-0D5AD7EA9164

P2860

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

http://www.wikidata.org/entity/Q34177267

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

@ast

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

@en

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

@nl

type

label

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

@ast

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

@en

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

@nl

prefLabel

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

@ast

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

@en

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

@nl

P1433

Q34177267-1580A8B2-1DCB-4D77-AA3A-0D8A55D59826

P1476

Q34177267-60C6C3E6-AFB1-4B11-B164-48A9E5FD6D4A

P2093

Q34177267-1DCEC090-CBA3-4988-927B-289D85D4C944

Q34177267-20245C98-E217-4771-A54B-5FC9CF196648

Q34177267-31620C51-C6B3-4637-AE9A-7AFA3CED5FF1

Q34177267-441B16FD-2606-45D3-BE06-0BFCE43CDD3F

Q34177267-49BBFACA-CDFD-488B-B136-EFD4E8E18CEC

Q34177267-917F0BF9-674E-4F2A-8237-0FA19A8EE010

Q34177267-94A04702-126C-42E4-B869-DE85253D7178

Q34177267-C3BADA00-C2E8-4CCD-BAD0-923EDAF958E9

Q34177267-C489699D-EDD6-4290-AB59-D85B959C59A8

P2860

Q34177267-0461112C-0250-40D9-A7CC-2C06966A479D

Q34177267-0463494B-A052-45DD-963A-966182B954F2

Q34177267-072BC63B-6A0D-4FEB-B415-7750B15188DD

Q34177267-0FAEB10E-F440-4E1E-92C2-227593FDA686

Q34177267-14508732-1680-44B9-8C03-4D3755066979

Q34177267-2B6C57DA-390C-4132-A8D1-ED4E10A3B2D7

Q34177267-2FADA08E-03A4-4457-ABC4-6DFC327DCDE3

Q34177267-30592AA2-52A7-4F61-8DA0-1540DC3FC8DB

Q34177267-329672FB-64A2-41C3-978C-ECAB51D1CE81

Q34177267-40394884-D878-4B7B-A030-CEFB6706EF01

P304

Q34177267-888DF5D4-AD4D-4F94-9B5C-224DC7D1B307

P31

Q34177267-F9E33CD5-4E96-4100-9687-DD1A59BBEA37

P356

Q34177267-D33C3E1F-92A4-47B2-938A-FDCC72BC45AE

P433

Q34177267-93C56E69-7581-4FC7-A01B-188BFD6B1F0D

P478

Q34177267-92A9BC21-5AA7-455D-81B7-255B275C15F6

P50

Q34177267-14F42202-6FD7-4AAD-9F9F-18E6B89A3ED4

Q34177267-3402D90B-C87D-489E-B789-F61FE78D4225

Q34177267-6B681046-F5D7-415F-9867-FBF94D57631E

Q34177267-70C1D584-A3FF-4343-8A17-71BC722F4BDB

Q34177267-D04D62BF-1243-4F2B-9BF4-89BCD3EF8D42

Q34177267-DC1BEE53-8AE7-4380-8A12-26C68761EC60

Q34177267-DDF52370-A356-4C6B-B68E-F67F52C9C47A

Q34177267-FAB93071-58C0-4AAA-B24F-2AE5B8F32BFE

P577

Q34177267-F57F0274-464A-4623-97FE-6B825743955F

P5875

Q34177267-497D5B2A-B82A-4632-801B-344EB402E432

P698

Q34177267-0D840068-575B-4481-B8C5-1C474D3160DB

P921

Q34177267-8BFA1DFA-4D49-45AB-8F9C-97AACED08C3A

P932

Q34177267-BE5EB109-E56F-49CB-AC80-83A1A80127A0

P356

P1433

Molecular Carcinogenesis

P1476

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

@en

P2093

Andrew Berchuck

http://www.w3.org/2001/XMLSchema#string

Brooke L Fridley

http://www.w3.org/2001/XMLSchema#string

Catherine M Phelan

http://www.w3.org/2001/XMLSchema#string

Ellen L Goode

http://www.w3.org/2001/XMLSchema#string

Kristin L White

http://www.w3.org/2001/XMLSchema#string

Melissa C Larson

http://www.w3.org/2001/XMLSchema#string

Ovarian Cancer Association Consortium

http://www.w3.org/2001/XMLSchema#string

Thomas A Sellers

http://www.w3.org/2001/XMLSchema#string

Xiaoqing Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants

Global cancer statistics, 2002

Common variants at 19p13 are associated with susceptibility to ovarian cancer.

SIFT: Predicting amino acid changes that affect protein function

Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies

Inherited determinants of ovarian cancer survival.

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.

Mutagenic, cancerogenic and teratogenic effects of alcohol.

Human class IV alcohol dehydrogenase: kinetic mechanism, functional roles and medical relevance.

P304

397-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MC.20714

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Georgia Chenevix-Trench

Penelope M. Webb

Robert Vierkant

Australian Ovarian Cancer Study Group

Jonathan Beesley

Joellen M Schildkraut

Julie M. Cunningham

P577

2010-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51039297

http://www.w3.org/2001/XMLSchema#string

P698

21480392

http://www.w3.org/2001/XMLSchema#string

P921

P932

3115705

http://www.w3.org/2001/XMLSchema#string